|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Humanigen (NASDAQ: HGEN) through any online brokerage.
The latest price target for Humanigen (NASDAQ: HGEN) was reported by Jefferies on September 10, 2021. The analyst firm set a price target for 9.00 expecting HGEN to rise to within 12 months (a possible 56.79% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Humanigen (NASDAQ: HGEN) is $5.74 last updated Tue Dec 07 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Humanigen.
Humanigen’s $Q4 earnings are confirmed for after-market on February 14, 2022.
There is no upcoming split for Humanigen.
Humanigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.